NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM386477 Query DataSets for GSM386477
Status Public on Apr 01, 2010
Title ALL fraction mRNAs 2 hours versus SHORT fraction mRNAs 2 hours replicate 3
Sample type RNA
 
Channel 1
Source name ALL fraction 2h - 3
Organism Homo sapiens
Characteristics cell line: HeLa
molecule: ALL fraction RNA
Treatment protocol HeLa cells were synchronized with double thymidine blockade (12 hours with 2 mM thymidine, 12 hours release, and 12 hours with 2 mM thymidine), and cells were taken after 2 hours release (S phase) and 8 hours release (G2/M phase).
Growth protocol HeLa cells were maintained in DMEM high glucose + 10% FCS + penicillin/streptomycin supplement.
Extracted molecule polyA RNA
Extraction protocol RNA was extracted using standard total RNA extraction protocol. Then for each condition total RNA was purified by two different procedures: poly(U) chromatography and oligo(dT)-chromatography. Poly(U)-chromatography (Jacobson, 1987): 100 μg of total RNA were bound to poly(U)-sepharose (Sigma) and eluted at 35ºC to isolate mRNAs with short poly(A) tail (<30As, SHORT fraction). Oligo(dT) chromatography: mRNAs were purified independently of their poly(A) tail length with Ambion Poly(A)Purist kit from 20 μg total RNA (ALL fraction). Jacobson, A. Purification and fractionation of poly(A)+ RNA. Methods in Enzymology (1987) 152: 254-261.
Label Cy5
Label protocol 100 ng of mRNA (ALL fraction mRNA or SHORT fraction mRNA) were reverse transcribed, amplified, labelled by in vitro transcription using the Low Input Linear Amplification Kit (Agilent 5184-3523), and hybridized following the manufacturer’s instructions.
 
Channel 2
Source name SHORT fraction 2h - 3
Organism Homo sapiens
Characteristics cell line: HeLa
molecule: SHORT fraction RNA
Treatment protocol HeLa cells were synchronized with double thymidine blockade (12 hours with 2 mM thymidine, 12 hours release, and 12 hours with 2 mM thymidine), and cells were taken after 2 hours release (S phase) and 8 hours release (G2/M phase).
Growth protocol HeLa cells were maintained in DMEM high glucose + 10% FCS + penicillin/streptomycin supplement.
Extracted molecule polyA RNA
Extraction protocol RNA was extracted using standard total RNA extraction protocol. Then for each condition total RNA was purified by two different procedures: poly(U) chromatography and oligo(dT)-chromatography. Poly(U)-chromatography (Jacobson, 1987): 100 μg of total RNA were bound to poly(U)-sepharose (Sigma) and eluted at 35ºC to isolate mRNAs with short poly(A) tail (<30As, SHORT fraction). Oligo(dT) chromatography: mRNAs were purified independently of their poly(A) tail length with Ambion Poly(A)Purist kit from 20 μg total RNA (ALL fraction). Jacobson, A. Purification and fractionation of poly(A)+ RNA. Methods in Enzymology (1987) 152: 254-261.
Label Cy3
Label protocol 100 ng of mRNA (ALL fraction mRNA or SHORT fraction mRNA) were reverse transcribed, amplified, labelled by in vitro transcription using the Low Input Linear Amplification Kit (Agilent 5184-3523), and hybridized following the manufacturer’s instructions.
 
 
Hybridization protocol Three biological replicate experiments were performed and SHORT fraction mRNAs was used as the common reference to compare with ALL fraction mRNAs. For all three biological replicates each experimental pair of labelled samples was co-hybridized on two separate microarrays with dye swapping to correct for dye bias effects. Thus, up to six microarray hybridizations were processed for each of the two comparisons - ALL fraction mRNAs versus SHORT fraction mRNAs at S phase (2 hours release after double thymidine blockade) and ALL fraction mRNAs versus SHORT fraction mRNAs at G2/M phase (8 hours release after double thymidine blockade)-, totalling 12 array datasets.
Scan protocol Fluorescent images were obtained using an Agilent G2565BA scanner at 100% PMT 100% laser power settings and quantified through the GenePix 6.0 software (Axon, Molecular Devices, Sunnywale, CA) using the irregular feature finding option.
Description ALL fraction mRNAs 2 hours versus SHORT fraction mRNAs 2 hours biological replicate 3 of 3. Technical replicate 1 of 2.
Data processing Extracted raw data were filtered and normalized using the Limma package developed within the Bioconductor project in the R statistical programming environment. The two channels were balanced by lowess normalization with reduced weights in control and poor quality spots, followed by scaling across chips. Differential expression analysis was performed using empirical Bayes statistics (Limma package, Smyth 2004) and SAM (Significance Analysis of Microarrays, Tusher et al. 2001).
 
Submission date Mar 25, 2009
Last update date Dec 22, 2009
Contact name Isabel Novoa
E-mail(s) isabel.novoa@crg.es
Organization name Center for Genomic Regulation
Department Gene Regulation
Street address Dr. Aiguader, 88
City Barcelona
ZIP/Postal code 08003
Country Spain
 
Platform ID GPL887
Series (1)
GSE15399 Global analysis of differential polyadenylation of mRNAs during mitotic cell cycle: S phase versus G2/M phase.

Data table header descriptions
ID_REF
VALUE Lowess normalized log2 ratio representing ALL fraction mRNAs versus SHORT fraction mRNAs.

Data table
ID_REF VALUE
12886 1.873116418
10752 1.901326773
722 0.958697742
2490 1.467446989
4086 1.939766643
18393 -0.090643834
5365 1.650160404
18164 1.920137394
17242 1.842115565
1487 1.562500363
7172 0.751290185
608 1.542487721
21787 1.7813756
8566 1.712717876
9360 1.844644849
13457 1.667908089
2965 1.622265958
5716 1.436304502
18641 1.529053356
17395 1.251614482

Total number of rows: 21073

Table truncated, full table size 367 Kbytes.




Supplementary file Size Download File type/resource
GSM386477_A05_BM_251209755185_polyA_2h_Cy5_rep3.gpr.gz 3.0 Mb (ftp)(http) GPR
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap